Your browser doesn't support javascript.
loading
Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study.
Odutola, Aderonke; Ota, Martin O C; Antonio, Martin; Ogundare, Ezra O; Saidu, Yauba; Foster-Nyarko, Ebenezer; Owiafe, Patrick K; Ceesay, Fatima; Worwui, Archibald; Idoko, Olubukola T; Owolabi, Olumuyiwa; Bojang, Abdoulie; Jarju, Sheikh; Drammeh, Isatou; Kampmann, Beate; Greenwood, Brian M; Alderson, Mark; Traskine, Magali; Devos, Nathalie; Schoonbroodt, Sonia; Swinnen, Kristien; Verlant, Vincent; Dobbelaere, Kurt; Borys, Dorota.
Afiliación
  • Odutola A; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: aaodutola@mrc.gm.
  • Ota MOC; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: otama@who.int.
  • Antonio M; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: mantonio@mrc.gm.
  • Ogundare EO; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: tundeyogundare@yahoo.com.
  • Saidu Y; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: ysaidu@clintonhealthaccess.org.
  • Foster-Nyarko E; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: efosternyarko@mrc.gm.
  • Owiafe PK; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: pkowiafe@uhas.edu.gh.
  • Ceesay F; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: faceesay@mrc.gm.
  • Worwui A; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: aworwui@mrc.gm.
  • Idoko OT; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: oidoko@mrc.gm.
  • Owolabi O; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: oowolabi@mrc.gm.
  • Bojang A; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: ambojang@mrc.gm.
  • Jarju S; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: shjarju@mrc.gm.
  • Drammeh I; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: idrammeh@mrc.gm.
  • Kampmann B; Medical Research Council Unit, Vaccines & Immunity Theme, Banjul, Gambia. Electronic address: bkampmann@mrc.gm.
  • Greenwood BM; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: Brian.Greenwood@lshtm.ac.uk.
  • Alderson M; PATH, Seattle, WA, USA. Electronic address: malderson@path.org.
  • Traskine M; GSK, Wavre, Belgium. Electronic address: magali.x.traskine@gsk.com.
  • Devos N; GSK, Wavre, Belgium. Electronic address: nathalie.i.devos@gsk.com.
  • Schoonbroodt S; GSK, Wavre, Belgium. Electronic address: sonia.j.schoonbroodt@gsk.com.
  • Swinnen K; GSK, Wavre, Belgium. Electronic address: kristien.m.swinnen@gsk.com.
  • Verlant V; GSK, Wavre, Belgium. Electronic address: vincent.verlant@gsk.com.
  • Dobbelaere K; GSK, Wavre, Belgium. Electronic address: dobbelaerekurt@gmail.com.
  • Borys D; GSK, Wavre, Belgium. Electronic address: dorota.d.borys@gsk.com.
Vaccine ; 35(19): 2531-2542, 2017 05 02.
Article en En | MEDLINE | ID: mdl-28389097
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae / Proteínas Bacterianas / Portador Sano / Nasofaringe / Vacunas Neumococicas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Streptococcus pneumoniae / Proteínas Bacterianas / Portador Sano / Nasofaringe / Vacunas Neumococicas Tipo de estudio: Clinical_trials / Risk_factors_studies Límite: Female / Humans / Infant / Male País/Región como asunto: Africa Idioma: En Año: 2017 Tipo del documento: Article